Stem Cell Research Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stem Cell Research

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Ian@SI	1/17/2007 1:20:31 PM
	of 495

7:31AM Geron: Studies show GERN's stem tcell therapeutic for spinal cord injury produces nerve growth factor (GERN) 8.65 : Co reported that studies show GRNOPC1, the co's human embryonic stem cell (hESC)-based oligodendroglial progenitor therapeutic, produces multiple nerve growth factors, proteins that stimulate the survival and regeneration of neurons damaged during spinal cord injury. Published in Stem Cells and Development (Vol. 15, Issue 6, 943-952), the studies conducted by Geron scientists describe a newly discovered neurotrophic effect that, in addition to the previously documented in vivo remyelinating activity of these cells (Journal of Neuroscience, 25 (19): 4694-4705, 2005), serves as a second mechanism of action that demonstrates the product's beneficial effects when injected into animal models of acute spinal cord injury.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next